Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous sodium ascorbate for severe traumatic brain injury
ACTRN12617001553369Phase 2Not yet recruiting
- Sponsor
- Professor Rinaldo Bellomo
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of sodium ascorbate in traumatic brain injury (TBI) (3 arms), sponsored by Professor Rinaldo Bellomo. Primary endpoints: Protocol adherence rate and Protocol enrolment rate. Planned start Jan 2018; status: not yet recruiting.
02
Drugs
sodium ascorbate
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on ACTRN12617001553369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617001553369.